G1T48, an oral selective estrogen receptor degrader, and the CDK4 6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine‑resistant breast cancer.pdf-_-_-f55d8e45-ff22-4d5e-852f-9c16cbd72e8.pdf
口服选择性雌激素受体降解剂G1T48和CDK4 6抑制剂lerociclib可抑制内分泌耐药性乳腺癌动物模型中的肿瘤生长-翻译.docx-_-_-db851e28-a041-4e0a-8c9e-4e710780bf5b.docx